Enhanced Peripartum Hemostatic Management Does Not Decrease Postpartum Hemorrhage Incidence in Hemophilia Carriers: the Pregnancy and Inherited Bleeding Disorders study (PRIDES).

Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B.

ImpaHCta-Haemophilia Carriers Quality of Life Assessment.

Successful management with regular factor IX replacement during pregnancy in a hemophilia B carrier: A case report.

Identification of Novel F9 Gene Variants in 143 Vietnamese Patients with Hemophilia B.

Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxes.

Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries-Comparisons to Matched Controls.

The history of women and hemophilia: a narrative review of evolving beliefs and testing practices.

The genetic analysis of eight families with hemophilia B in Mongolia: Identification of two novel mutation.

Proactive systematic hemophilia carrier screening: a step toward gender equity in hemophilia care.

Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors.

Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays.

Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B.

Clinical Analysis and Mental Health Survey of Hemophilia Carriers: a Cross-sectional Study.

Adherence tool for prophylactic haemophilia treatment in adult and adolescent patients: A systematic review and meta-analysis protocol.

Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B.

Thromboembolic Disease in Haemophilic Patients Undergoing Major Orthopaedic Surgery: Is Thromboprophylaxis Mandatory?

Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.

Managing Pregnant Women with Hemophilia and von Willebrand Disease: How Do We Provide Optimum Care and Prevent Complications?

Delivery of Cas9-guided ABE8e into stem cells using poly(l-lysine) polypeptides for correction of the hemophilia-associated FIX missense mutation.

"Haemophilia A" - Presenting with oral squamous cell carcinoma diagnosis and management strategies.

Investigation of the Bleeding Tendency in Sudanese Female Carriers of Hemophilia B.

Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.

Management and outcomes of mild hemophiliacs and hemophilia carriers during pregnancy and peripartum period: a hemophilia treatment center experience in the United States.

Mutation analysis and characterisation of F9 gene in haemophilia- B population of India.

F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.

Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset.

Preclinical development of plant-based oral immune modulatory therapy for haemophilia B.

Consensus on hemophilia in Mexico.

Genetic analysis of carrier status in female members of Japanese hemophilia families.

Evaluation of bleeding symptoms and laboratory parameters related to bleeding in sisters of patients with hemophilia A and B.

Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review.

Hemophilia carriers and women with coagulopathies: challenges in the occupational arena.

Hemophilia carriers: quality of life and management at different life stages.

Carriers of haemophilia: pregnancy, childbirth and postpartum.

Genetic causes of haemophilia in women and girls.

X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues.

Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.

Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study.

Postpartum bleeding in women with inherited bleeding disorders: a matched cohort study.

Hemophilia B - Mutation Rates and Incidence - A Simulation Study.

Pregnancy outcomes in female carriers of haemophilia B Leyden.

Role of Small Intestine and Gut Microbiome in Plant-Based Oral Tolerance for Hemophilia.

The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review.

Genetic mosaicism in haemophilia: A practical review to help evaluate the risk of transmitting the disease.

Molecular characterization of hemophilia B patients in Colombia.

EHL-FIX in haemophilia B carriers with FIX deficiency.

Maternal and neonatal outcomes in carriers of haemophilia A and B: A Swedish Medical Birth Register study.

Mothers' intentions and behaviours regarding providing risk communication to their daughters about their possibility of being haemophilia carriers: A qualitative study.

Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

Compensated pathogenic variants in coagulation factors VIII and IX present complex mapping between molecular impact and hemophilia severity.

Genetic analysis of a hemophilia B family with a novel F9 gene mutation: A STROBE-compliant article.

[HEMOPHILIA - A ROYAL DISEASE IN THE HOLY LAND].

The characteristics and spectrum of F9 mutations in Chinese sporadic haemophilia B pedigrees.

Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IX.

Hemophilia B in a female with intellectual disability caused by a deletion of Xq26.3q28 encompassing the F9.

Screening of haemophilia carriers in moderate and severe haemophilia A and B: Prevalence and determinants.

High resolution melting for F9 gene mutation analysis in patients with haemophilia B.

Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.

Targeting anticoagulant protein S to improve hemostasis in hemophilia.

Establishing a comprehensive genetic diagnosis strategy for hemophilia B and its application in Chinese population.

The spectrum of bleeding in women and girls with haemophilia B.

Noninvasive prenatal diagnosis for X-linked disease by maternal plasma sequencing in a family of Hemophilia B.

Comparative study of the prevalence of clotting factor deficiency in carriers of haemophilia A and haemophilia B.

"It was a lot Tougher than I Thought It would be". A Qualitative Study on the Changing Nature of Being a Hemophilia Carrier.

Rare bleeding disorders-old diseases in the era of novel options for therapy.

Multiplex ligation-dependent probe amplification as first mutation screening for large deletions and duplications in haemophilia.

Systemic delivery of factor IX messenger RNA for protein replacement therapy.

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study.

Biodegradable hydrophilic carriers for the oral delivery of hematological factor IX for hemophilia B treatment.

Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disability.

Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.

Genetic diagnosis in hemophilia and von Willebrand disease.

Treatment of hemophilia: A qualitative study of mothers' perspectives.

Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures.

Using genetic diagnostics in hemophilia and von Willebrand disease.

Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia.

Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.

Age-related factor IX correction in symptomatic female carriers with haemophilia B Leyden.

Factor levels in carriers of haemophilia are associated with familial severity: a Danish single centre study.

Hemophilia B: molecular pathogenesis and mutation analysis.

Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.